Heroin-Induced Leukoencephalopathy.

Cureus

Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA.

Published: February 2021

Heroin-induced leukoencephalopathy (HLE) is a rare but potentially debilitating and sometimes fatal neurological disorder. Despite the widely practiced heroin use via different routes and modalities, the syndrome is said to be rare and mostly associated with inhaling rather than injecting or snorting practices. We reviewed the literature to address the latest diagnostic, therapeutic, and prognostic measures related to the condition. Here, we present a case of a 35-year-old male who admitted to inhaling heroin 18 days ago and has been experiencing ongoing neurological symptoms for the past 17 days. Imaging was consistent with extensive white matter disease at multiple levels and different anatomical regions. Although there is no known cure for HLE, the patient benefited, somewhat, from antioxidants and physical rehabilitation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935071PMC
http://dx.doi.org/10.7759/cureus.13093DOI Listing

Publication Analysis

Top Keywords

heroin-induced leukoencephalopathy
8
leukoencephalopathy heroin-induced
4
leukoencephalopathy hle
4
hle rare
4
rare debilitating
4
debilitating fatal
4
fatal neurological
4
neurological disorder
4
disorder despite
4
despite practiced
4

Similar Publications

Heroin-Induced Leukoencephalopathy: A Case Report.

Cureus

August 2024

Multiple Sclerosis, Neurology, Holy Name Hospital, Teaneck, USA.

Article Synopsis
  • Heroin-induced leukoencephalopathy (HLE) is a rare but serious condition linked to inhaling heroin, known as "chasing the dragon," resulting in various neurological symptoms.
  • A case study is presented involving a 27-year-old woman who experienced worsening neurological issues after two years of using recreational heroin through inhalation.
  • MRI scans showed specific brain changes indicative of the condition, and the study will outline her clinical progression over a one-year follow-up period.
View Article and Find Full Text PDF

Heroin-induced leukoencephalopathy: Chasing the imaging findings.

Radiol Case Rep

September 2024

Department of Radiology, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, NY, USA.

We present a case of a 29-year-old male who was brought into the hospital due to unresponsiveness and found to have heroin inhalational leukoencephalopathy (HLE). HLE is one component of a broad spectrum of opioid encephalopathies that is associated with heroin inhalation and other opioids. There is considerable overlap of HLE with other toxic and hypoxic-ischemic encephalopathies; however, the specific territories of brain involvement help distinguish it from other cerebral insults.

View Article and Find Full Text PDF

A man in his late 40s with no known past medical history was unresponsive for an unknown period of time. Crushed pills and white residue were found on a nearby table. On presentation he was obtunded and unresponsive to verbal commands but withdrawing to painful stimuli.

View Article and Find Full Text PDF

The dangers of "Chasing the dragon": a fatal case of heroin-induced leukoencephalopathy.

BJR Case Rep

January 2024

Department of Neuroradiology, "Hôpital des Spécialités", Rabat, 10170, Morocco.

Heroin-induced leukoencephalopathy (HLE) is a rare toxic encephalopathy associated primarily with heroin inhalation, commonly referred to as "chasing the dragon." This study presents a clinical case of a 27-year-old polydrug user diagnosed with HLE during hospitalization for rapidly progressive flaccid tetraplegia and aphasia. The clinical manifestations encompassed cerebellar and bulbar dysfunction, coupled with motor impairment and altered consciousness.

View Article and Find Full Text PDF

Heroin-induced leukoencephalopathy (HLE) is a rare condition with acute and chronic outcomes ranging from mild neurological symptoms to severe neurological deficits and death. HLE is caused by cerebral white matter damage secondary to exposure to toxic agents such as chemotherapeutic drugs, environmental toxins, and drugs of abuse. Here, we present the case of a 20-year-old woman with a past medical history significant for bipolar disorder and opioid use who presented to the emergency department with ataxia, involuntary movements, and altered mental status secondary to inhalational heroin use.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!